When Patents Persist

When Patents Persist What if that patent you’re paying royalties on suddenly gets extended? Have you negotiated the best licensing deal possible?

Amgen's Cannibalistic Ways

Amgen’s Cannibalistic Ways If you don’t think that Amgen is excited about its future, check out what the company is piling on its plate. The biotech giant will be earmarking half of next year’s revenue to launch a $5 billion share buyback.

Get email updates

Get new actionable insights and updates from BiotechBlog